`Tel: 571-272-7822
`
`
`
`Paper No. 103
`Entered: July 8, 2022
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner,
`
`v.
`
`NOVARTIS PHARMA AG, NOVARTIS TECHOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owner.
`_____________
`
`IPR2021-00816
`Patent 9,220,631 B2
`______________
`
`Before ERICA A. FRANKLIN, ROBERT L. KINDER, and
`JAMIE T. WISZ, Administrative Patent Judges.
`
`KINDER, Administrative Patent Judge.
`
`
`
`
`
`ORDER
`Granting Patent Owner’s Third, Fourth, and Fifth Motions to Seal;
`Granting Patent Owner’s Motion for Entry of Second Modified Default
`Protective Order
`37 C.F.R. §§ 42.14 and 42.54
`
`
`
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`
`Introduction
`
`I.
`Novartis Pharma AG, Novartis Technology LLC, and Novartis
`Pharmaceuticals Corporation (collectively, “Novartis” or “Patent Owner”)
`filed a Third Motion to Seal portions of the Patent Owner’s Response (Paper
`35, “PO Resp.”), portions of Patent Owner’s Motion to Amend (Paper 37,
`“MTA”), and Exhibits 2099–2115, 2119–2121, 2123, 2124, 2126, 2128–
`2134, 2136–2148, 2150, 2155–2159, 2166–2172, 2194, 2201, 2203–2206,
`2208, 2224, and 2254. Paper 38, 1 (“Third Mot.”). Along with the Third
`Motion, Patent Owner filed redacted public versions of the exhibits listed
`above, excepting Exhibits 2099–2115, 2132, and 2194, which were subject
`to a protective order in a related proceeding before the International Trade
`Commission (“ITC”) regarding U.S. Patent No. 9,220,631 (“the ’631
`patent”) and contain third party confidential information. Redacted public
`versions of Patent Owner’s Response (Paper 40) and Motion to Amend
`(Paper 36) have also been filed.
`In its Third Motion, Patent Owner also moves for entry of a Second
`Modified Default Protective Order (Ex. 2323), and Petitioner does not
`oppose. Third. Mot. 1.
`Patent Owner also filed a Fourth Motion to Seal Exhibits 2337 and
`2338.1 Paper 85, 1 (“Fourth Mot.”). Patent Owner did not file a redacted
`public version of Exhibit 2337, which was subject to the ITC protective
`order and contains third party confidential information.
`
`
`1 Exhibit 2338 has been expunged.
`
`
`
`2
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`Patent Owner also filed a Fifth Motion to Seal portions of Patent
`Owner’s Surreply to Petitioner’s Reply (Paper 92, “Surreply”), Exhibits
`2339, 2345, and 2347 (unredacted versions), and Exhibits 2341–2344, 2346,
`and 2348–2352. Paper 90, 1 (“Fifth Mot.”). Along with the Fifth Motion,
`Patent Owner filed public redacted versions of Exhibits 2339, 2345, and
`2347 (Exs. 2339, 2345, and 2347) and a redacted public version of Patent
`Owner’s Surreply to Petitioner’s Reply (Paper 93). Patent Owner has not
`filed redacted public versions of Exhibits 2341–2344, 2346, and 2348–2352,
`which were subject to the ITC protective order.
`For the reasons set forth below, Patent Owner’s Third, Fourth, and
`Fifth Motions to Seal are granted.
`II. Motion to Seal Legal Standard
`“There is a strong public policy for making all information filed in a
`
`quasi-judicial administrative proceeding open to the public.” Garmin Int’l v.
`Cuozzo Speed Techs., LLC, IPR2012–00001, slip op. at 1–2 (PTAB Mar. 14,
`2013) (Paper 34). The record for an inter partes review shall be made
`available to the public, except as otherwise ordered, and a document filed
`with a motion to seal shall be treated as sealed until the motion is decided.
`35 U.S.C. § 326(a)(1); 37 C.F.R. § 42.14. The standard for granting a
`motion to seal is “good cause.” 37 C.F.R. § 42.54; see also Argentum
`Pharms. LLC v. Alcon Res., Ltd., IPR2017-01053, Paper 27 at 3–4 (PTAB
`Jan. 19, 2018) (Informative) (describing the “good cause” standard). The
`moving party bears the burden of showing that the relief requested should be
`granted. 37 C.F.R. § 42.20(c). That includes showing that the information
`is truly confidential, and that such confidentiality outweighs the strong
`public interest in having an open record. See Argentum, Paper 27 at 3–4
`
`
`
`3
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`(“[A] movant to seal must demonstrate adequately that (1) the information
`sought to be sealed is truly confidential, (2) a concrete harm would result
`upon public disclosure, (3) there exists a genuine need to rely in the trial on
`the specific information sought to be sealed, and (4), on balance, an interest
`in maintaining confidentiality outweighs the strong public interest in having
`an open record.”).
`
`III. Patent Owner’s Motions to Seal
`In its Third Motion, Patent Owner attests that the documents it seeks
`to seal contain truly confidential information. Third Mot. 2 (stating
`“Novartis’s confidential research and development related to the subject
`matter of U.S. Patent No. 9,220,631 (“the ’631 patent”), Novartis’s
`confidential commercial information, third party confidential information, or
`information that is subject to contractual or statutory obligations of
`confidentiality to third party companies or individuals . . . . has not been
`published or otherwise made public”). Patent Owner also attests a concrete
`harm would result upon public disclosure of the information. Id. at 2
`(stating disclosure “would competitively harm Novartis’s and/or the third
`parties’ business prospects and put these companies at a competitive
`disadvantage” and “could subject Novartis to civil and criminal penalties
`under the laws of Switzerland”). Patent Owner attests that it relies on these
`documents to support its arguments regarding, for example, secondary
`considerations of non-obviousness. Id. at 3. Patent Owner further attests
`that the redactions in the documents it seeks to seal are “narrowly tailored.”
`Id.
`
`Patent Owner makes similar attestations in its Fourth and Fifth
`Motions to Seal. Fourth Mot. 2–3; Fifth Mot. 2–3.
`
`
`
`4
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`We find Patent Owner’s showing persuasive in establishing good
`cause to seal the identified documents, and we individually address each of
`Patent Owner’s Third, Fourth, and Fifth Motions to Seal in more detail
`below.
`
`i.
`
`1. Third Motion
`Exhibits 2099–2115, 2119–2121, 2123, 2124, 2126, 2128–
`2134, 2136–2148, 2150, 2155–2159, 2166–2172, 2194, 2201,
`2203–2206, 2208, 2224, and 2254
`Exhibits 2120, 2126, 2128–2131, 2136–2145, 2150, 2224, 2254 are
`Patent Owner’s confidential technical documents, including presentations
`discussing research and development of the ʼ631 patent and project
`timelines, reports prepared for submission to regulatory authorities, and
`emails regarding creating a product. Third Mot. 3. Exhibits 2119, 2121,
`2123, 2124, 2132–2134, 2146, 2147, and 2155–2159 are Patent Owner’s
`confidential commercial information, specifically contracts between Patent
`Owner and third parties. Id. at 7. Exhibits 2099–2115, 2148, and 2194 are
`third party (i.e., Genentech, Inc.) confidential documents produced in the
`related ITC investigation. Id. at 9. Exhibits 2166–21722 are Patent Owner’s
`confidential internal business and financial documents, and declarations
`discussing those documents. Id. at 10. Exhibits 2201, 2203–2206, and 2208
`are Patent Owner declarations, filed in support of Patent Owner’s briefs, that
`contain information regarding Patent Owner’s and third party proprietary
`technical and development information, confidential business information of
`
`
`2 Patent Owner also lists Exhibit 2173. Third Mot. 10. However, this
`appears to be a harmless typographical error, as Exhibit 2173 has not been
`filed in this case.
`
`
`
`5
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`third parties, and references to exhibits with confidential information (e.g.,
`Exhibits 2099–2115, 2119–2121, etc.). Id. at 11–13.
`Patent Owner filed corresponding public redacted versions of these
`exhibits, with the exception of Exhibits 2099–2115, 2132, and 2194, which
`appear to have been subject to a protective order in the related ITC
`investigation. Patent Owner asserts that “[t]hese documents were part of the
`record developed in the ITC action, and in that action, these documents were
`subject to a protective order requiring that these documents only be
`accessible by outside counsel.” Third Mot. 10. Patent Owner further
`explains that “[t]he parties to this IPR proceeding have agreed to modify the
`protective order in this action to extend the same level of protection for these
`documents as was provided in the ITC action.” Id. Patent Owner makes
`similar assertions in each motion to seal regarding documents subject to a
`protective order in the ITC proceeding. See, e.g., Fourth Mot. 3–4.
`We note Exhibits 2099–2115, 2132, and 2194 contain confidential
`information of third parties, were deemed to be protected in the related ITC
`investigation, and do not appear to be central to the dispute in the present
`case.
`
`Based on Patent Owner’s various attestations and its filing of public
`redacted versions, we determine that Patent Owner has sufficiently shown
`that the information sought to be sealed is truly confidential, would result in
`harm if disclosed, is pertinent to the ongoing trial, and that maintaining
`confidentiality outweighs the strong public interest in having an open record.
`As such, Patent Owner has established good cause for sealing Exhibits
`2099–2115, 2119–2121, 2123, 2124, 2126, 2128–2134, 2136–2148, 2150,
`
`
`
`6
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`2155–2159, 2166–2172, 2194, 2201, 2203–2206, 2208, 2224, and 2254.
`Patent Owner Response and Motion to Amend
`ii.
`Patent Owner seeks to seal the unredacted versions of the Patent
`Owner Response and Motion to Amend, which “discuss the confidential
`information disclosed in the Exhibits that Novartis currently seeks to seal” in
`its Third Motion. Third Mot. 14. Patent Owner states that the information
`redacted from the public versions “does not impede the public’s
`understanding of the file history of the ’631 patent.” Id.
`Based on this evidence and argument, we are persuaded that the
`redacted information does not appear to unreasonably impede the public’s
`understanding of the record, and for reasons similar to those discussed above
`in this Order, we are further persuaded that Patent Owner’s showing
`establishes good cause for redacting the information it seeks to keep
`confidential in the Patent Owner Response and Motion to Amend.
`2. Fourth Motion
`
`Exhibit 2337
`i.
`Exhibit 2337 is a deposition transcript of Petitioner’s expert witness,
`James Agallaco, taken in the related ITC investigation. Fourth Mot. 3.
`According to Patent Owner, Exhibit 2337 contains information on Patent
`Owner’s business relationships with third parties as well as third party
`confidential business information. Id. Patent Owner explains that public
`disclosure of this transcript would result in harm, and that Patent Owner
`relies on Exhibit 2337 “to rebut [Petitioner’s] arguments concerning the
`claims of the ’631 Patent.” Id. at 2–3.
`Patent Owner has not filed a public redacted version of Exhibit 2337.
`However, Exhibit 2337 contains confidential information of non-parties, was
`
`
`
`7
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`deemed to be protected in the related ITC investigation, and does not appear
`to be central to the dispute in the present case.
`For reasons similar to those already discussed in this Order, we
`determine Patent Owner’s showing is persuasive to establish good cause to
`seal Exhibit 2337.
`
`i.
`
`3. Fifth Motion
`Exhibits 2339, 2345, and 2347 (unredacted versions), and
`Exhibits 2341–2344, 2346, and 2348–2352
`Exhibits 2339, 2341, 2345, 2347, and 2348 are cross-examination
`deposition transcripts of Petitioner’s witnesses taken in this IPR proceeding.
`Fifth Mot. 2. According to Patent Owner, these depositions discuss
`confidential information. Id. at 3. Exhibit 2346 is a deposition transcript of
`a third party witness taken in this IPR proceeding. Id. The deposition
`discusses multiple documents that contain third party confidential and
`proprietary development, research, and sales information. Id. Exhibits
`2342–2344 and 2349–2352 are Petitioner’s documents (containing
`confidential and proprietary research, development, manufacture, and
`business information), which were part of the record developed in the ITC
`investigation. Id. at 4.
`Patent Owner has not filed public redacted versions of Exhibits 2341–
`2344, 2346, and 2348–2352. However, these exhibits contain Petitioner’s
`and third party confidential information, were deemed to be protected in the
`related ITC investigation, and do not appear to be central to the dispute in
`the present case.
`For reasons similar to those already discussed in this Order, we
`determine Patent Owner’s showing is persuasive to establish good cause to
`
`
`
`8
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`seal Exhibits 2339, 2345, and 2347 (unredacted versions), and Exhibits
`2341–2344, 2346, and 2348–2352.
`Patent Owner’s Surreply
`ii.
`Patent Owner seeks to seal the unredacted version of its Surreply (the
`Surreply discusses the confidential information in Exhibits 2339 and 2341–
`2352). Fifth Mot. 2. We determine that this paper contains confidential
`information, disclosure of which would harm Patent Owner and/or third
`parties. Furthermore, at the present time, the redacted information does not
`appear to be essential for the public’s understanding. We determine Patent
`Owner’s showing is persuasive to establish good cause for redacting the
`information it seeks to keep confidential in the Patent Owner Surreply.
`IV. Conclusion on Motions to Seal
`In reviewing Patent Owner’s Third, Fourth, and Fifth Motions,
`Petitioner’s Motion to Seal, and relevant documents, we are persuaded of
`good cause to seal these papers and exhibits.
`Accordingly, we grant Patent Owner’s Third Motion to Seal the
`unredacted versions of Patent Owners’ Response, Patent Owner’s Motion to
`Amend, and Exhibits 2099–2115, 2119–2121, 2123, 2124, 2126, 2128–
`2134, 2136–2146, 2148, 2150, 2155–2159, 2166– 2172, 2194, 2201, 2203–
`2206, 2208, 2224, and 2254.
`We further grant Patent Owner’s Fourth Motion to Seal Exhibit 2337.
`We further grant Patent Owner’s Fifth Motion to Seal portions of
`Patent Owner’s Surreply to Petitioner’s Reply, Exhibits 2339, 2345, and
`2347 (unredacted versions), and Exhibits 2341–2344, 2346, and 2348–2352.
`Second Modified Default Protective Order
`V.
`Our rules provide for entry of a protective order when necessary to
`
`
`
`9
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`protect confidential information filed in a proceeding. See 37 C.F.R.
`§§ 42.14, 42.54. Patent Owner’s Second Modified Default Protective Order
`(Ex. 2323) includes proposed changes to the Modified Default Protective
`Order of record (Ex. 2091).3 Further, as noted above, Patent Owner explains
`that the parties to this IPR proceeding have agreed to modify the protective
`order in this action to extend the same level of protection to certain
`documents as was provided in the ITC action. See Third Mot. 10; Ex. 2323.
`The changes to the Modified Default Protective Order appear reasonable.
`Accordingly, we grant Patent Owner’s Motion to enter the Second
`Modified Default Protective Order (Paper 38).
`VI. Order
`
`Accordingly, it is:
`ORDERED that Patent Owner’s Third Motion to Seal (Paper 38) is
`granted, and the unredacted versions of Patent Owner’s Response (Paper
`35), Patent Owner’s Motion to Amend (Paper 37), and Exhibits 2099–2115,
`2119–2121, 2123, 2124, 2126, 2128–2134, 2136–2148, 2150, 2155–2159,
`2166– 2172, 2194, 2201, 2203–2206, 2208, 2224, and 2254 shall remain
`under seal;
`FURTHER ORDERED that Patent Owner’s Fourth Motion to Seal
`(Paper 85) is granted, and Exhibit 2337 shall remain under seal;
`FURTHER ORDERED that Patent Owner’s Fifth Motion to Seal
`(Paper 90) is granted, and Patent Owner’s Surreply to Petitioner’s Reply
`(Paper 92), Exhibits 2339, 2345, and 2347 (unredacted versions), and
`
`
`3 We previously granted Patent Owner’s Motion to enter a Modified Default
`Protective Order (Paper 9). Paper 15. Patent Owner attests that the
`proposed changes to the previously entered Modified Default Protective
`Order (Ex. 2091) are shown in Exhibit 2324. Third Mot. 1.
`10
`
`
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`Exhibits 2341–2344, 2346, and 2348–2352 shall remain under seal; and
`FURTHER ORDERED that Patent Owner’s Motion to enter the
`Second Modified Default Protective Order (Paper 38) is granted, and the
`Second Modified Default Protective Order (Exhibit 2323) is hereby entered.
`
`
`
`
`
`
`
`
`
`
`11
`
`
`
`IPR2021-00816
`Patent 9,220,631 B2
`FOR PETITIONER:
`
`Anish Desai
`Elizabeth Weiswasser
`Christopher Pepe
`WEIL, GOTSHAL & MANGES LLP
`anish.desai@weil.com
`elizabeth.weiswasser@weil.com
`christopher.pepe@weil.com
`
`
`
`
`For PATENT OWNER:
`
`Elizabeth Holland
`Nicholas Mitrokostas
`William G. James
`ALLEN & OVERY LLP
`elizabeth.holland@allenovery.com
`nicholas.mitrokostas@allenovery.com
`william.james@allenovery.com
`
`
`Linnea Cipriano
`Duncan Greenhalgh
`Joshua Weinger
`GOODWIN PROCTER LLP
`lcipriano@goodwinlaw.com
`dgreenhalgh@goodwinlaw.com
`jweinger@goodwinprocter.com
`
`
`
`
`12
`
`